Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Prescriptions"
Filter
Filter
Article category
Keywords
Publication year
Authors
COVID-19: Original Article
Influence of practice location on prescribing, diabetes care, and colorectal cancer screening among Czech general practitioners during the COVID-19 pandemic
Jan Bělobrádek, Luděk Šídlo, Tom Philipp
Epidemiol Health. 2024;46:e2024033.   Published online February 23, 2024
DOI: https://doi.org/10.4178/epih.e2024033
  • 4,116 View
  • 94 Download
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The provision of primary health care was not interrupted during the coronavirus disease 2019 (COVID-19) pandemic in Czechia, although the capacity and resources of providers changed. We examined how the pandemic affected individual general practices throughout 2017-2021, focusing on differences between urban and rural practices.
METHODS
We analysed data from the largest health insurance company in Czechia, which provides care to 4.5 million people (60% of the population). We evaluated the prescription volume, diabetes care procedures, and faecal immunochemical test (FIT) in preventive care and new pandemic-related procedures (remote consultations, testing, and vaccinations). For the spatial distribution of practices, we adapted the Organisation for Economic Cooperation and Development typology.
RESULTS
We observed minimal declines in 2020 in the rate of prescribing (-1.0%) and diabetes care (-5.1%), with a rapid resumption in 2021, but a substantial decline in FIT (-17.8% in 2020) with slow resumption. Remote consultations were used by 94% of all practices regardless of location, with testing and vaccinations more commonly performed by rural general practitioners (GPs).
CONCLUSIONS
Primary care in Czechia rose to the challenge of the COVID-19 pandemic, as shown by the finding that the volume of healthcare services provided through primary care did not decrease across most of the monitored parameters. This study also confirmed that rural GPs provide more care in-house, both in terms of prescribing and procedures performed in their practices. Future studies will need to focus on preventive care, which the pandemic has dampened in GP practices in Czechia.
Summary
Key Message
Primary care in Czechia has effectively adapted to the changes brought about by the COVID-19 pandemic. Minimal impact was observed in prescribtions and diabetic patient care. There was a significant decline in colorectal cancer screening, with a slow restitution after the pandemic subsided. Rural GPs consistently provided in-house treatment and have higher shares of both prescribing and diabetes care, as well as performing more COVID-19 specific procedures.
Brief Communication
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
Inmyung Song, Ju-Young Shin
Epidemiol Health. 2016;38:e2016045.   Published online October 26, 2016
DOI: https://doi.org/10.4178/epih.e2016045
  • 14,961 View
  • 270 Download
  • 15 Web of Science
  • 15 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011.
METHODS
Using the Korea National Health Insurance claims database, we identified patients between one and 17 years of age who had at least one medical claim for the diagnosis of ADHD (International Classification of Diseases, 10th revision: F90.0). The annual prevalence of ADHD diagnoses was calculated, using national census data from Statistics Korea on the population aged between one and 17 years as the denominator. The prevalence was age-standardized using the 2010 population as the standard population. The number of patients who were treated with methylphenidate and/or atomoxetine and the prevalence of total patients with ADHD that were treated with either drug were also calculated for each year. All analyses were stratified according to gender and age group (1-5 years, 6-12 years, and 13-17 years).
RESULTS
The number of patients diagnosed with ADHD increased from 72,704 persons (0.71%) in 2007 to 85,468 persons (0.93%) in 2011. The annual age-standardized prevalence of ADHD diagnoses increased from 0.67% in 2007 to 0.94% in 2011. The prevalence of methylphenidate use among children and adolescents with ADHD decreased from 73.91% in 2007 to 70.33% in 2011, whereas that of atomoxetine use increased from 5.77% in 2009 to 13.09% in 2011.
CONCLUSIONS
While methylphenidate remains the most commonly prescribed ADHD drug, the use of atomoxetine has increased.
Summary
Korean summary
전국민보험자료를 분석한 본 연구에 따르면 한국의 17세 이하 소아인구에서 주의력결핍과다행동장애(ADHD) 진단을 받은 환자의 비율이 2007년 0.71%에서 2011년 0.93%로 증가하였다. ADHD 진단받은 환자 중 메틸페니데이트를 처방받은 환자 비율은 2007년 73.91%에서 2011년 70.33%로 감소한 반면, 아토목세틴을 처방받은 환자 비율을 2009년 5.77%에서 2011년 13.09%로 증가하였다

Citations

Citations to this article as recorded by  
  • Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
    Kentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, Saori Inoue, Maya Okazawa, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu‐Ichi Ueno
    Neuropsychopharmacology Reports.2024; 44(1): 29.     CrossRef
  • Association between children with attention-deficit hyperactivity disorder and parental mental health: Data from the 2011–2020 Korea National Health and Nutrition Examination Survey
    Woolim Ko, Hyunsuk Jeong
    Journal of Affective Disorders.2024; 350: 544.     CrossRef
  • Investigating Variations in Medicine Approvals for Attention-Deficit/Hyperactivity Disorder: A Cross-Country Document Analysis Comparing Drug Labeling
    Laila Tanana, Asam Latif, Prasad S Nishtala, Timothy F Chen
    Journal of Attention Disorders.2024; 28(11): 1437.     CrossRef
  • Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea
    Yoon Cho, Ah-Young Kim, Sukhyang Lee, Hankil Lee
    International Clinical Psychopharmacology.2024; 39(4): 240.     CrossRef
  • Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
    Jae Heon Kim, Suyeon Park, Yeon Jung Lee
    Journal of the Korean Academy of Child and Adolescent Psychiatry.2023; 34(2): 125.     CrossRef
  • Minnesota Multiphasic Personality Inventory‐Adolescent‐Restructured Form (MMPI‐A‐RF) characteristics of ADHD in a Korean psychiatric sample
    Cheryl Chakranarayan, Nathan C. Weed, Kyunghee Han, Reid L. Skeel, Kyungjoo Moon, Ji‐Hae Kim
    Journal of Clinical Psychology.2022; 78(5): 913.     CrossRef
  • Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
    Laila Tanana, Christopher Harrison, Prasad S. Nishtala, Timothy F. Chen
    European Neuropsychopharmacology.2022; 65: 68.     CrossRef
  • Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Luise Kazda, Katy Bell, Rae Thomas, Kevin McGeechan, Rebecca Sims, Alexandra Barratt
    JAMA Network Open.2021; 4(4): e215335.     CrossRef
  • Drug Prescriptions for Children With ADHD in Japan: A Study Based on Health Insurance Claims Data Between 2005 and 2015
    Makiko Yoshida, Taku Obara, Saya Kikuchi, Michihiro Satoh, Yoshihiko Morikawa, Nobuhiro Ooba, Hiroaki Yamaguchi, Nariyasu Mano
    Journal of Attention Disorders.2020; 24(2): 175.     CrossRef
  • Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change
    Eonjeong Kim, Susin Park, Yewon Kim, Nam Kyung Je
    International Clinical Psychopharmacology.2020; 35(6): 329.     CrossRef
  • The female side of pharmacotherapy for ADHD—A systematic literature review
    Francien M. Kok, Yvonne Groen, Anselm B. M. Fuermaier, Oliver Tucha, Gerard Hutchinson
    PLOS ONE.2020; 15(9): e0239257.     CrossRef
  • Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data
    Daniele Piovani, Antonio Clavenna, Maurizio Bonati
    European Journal of Clinical Pharmacology.2019; 75(10): 1333.     CrossRef
  • The Symptom Trajectory of Attention-Deficit Hyperactivity Disorder in Korean School-Age Children
    Kyoung Min Kim, Mina Ha, Myung Ho Lim, Ho-Jang Kwon, Seung-Jin Yoo, Eunjung Kim, Ki Chung Paik
    Psychiatry Investigation.2018; 15(5): 470.     CrossRef
  • Parental smoking and depression, and attention‐deficit hyperactivity disorder in children and adolescents: Korean national health and nutrition examination survey 2005‐2014
    Youn Joo Cho, Ran Choi, Susan Park, Jin‐won Kwon
    Asia-Pacific Psychiatry.2018;[Epub]     CrossRef
  • Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives
    Jordan Amadio, Guo-Qiang Bi, Paul Frederick Boshears, Adrian Carter, Anna Devor, Kenji Doya, Hermann Garden, Judy Illes, L. Syd M. Johnson, Lyric Jorgenson, Bang-Ook Jun, Inyoung Lee, Patricia Michie, Tsuyoshi Miyakawa, Eisuke Nakazawa, Osamu Sakura, Hago
    Neuron.2018; 100(1): 19.     CrossRef

Epidemiol Health : Epidemiology and Health
TOP